STIM
NASDAQ HealthcareNeuronetics, Inc. - Common Stock
Medical Devices
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
�� 市场数据
| 价格 | $1.78 |
|---|---|
| 成交量 | 11,791,572 |
| 市值 | 123.87M |
| 贝塔系数 | 1.060 |
| RSI（14日） | 80.7 超买 |
| 200日均线 | $1.72 |
| 50日均线 | $1.43 |
| 52周最高 | $4.85 |
| 52周最低 | $0.80 |
| Forward P/E | -5.29 |
| Price / Book | 9.32 |
🎯 投资策略评分
STIM 在各投资策略中的评分。分数越高，越符合该策略目标。
🔍 策略解读
最佳匹配： 🎈 Over-Hyped (95/100) — 此策略 超买股票（潜在做空标的）.
评分最低的策略： 🐋 Institutional Whale (1/100). 单一评分不构成买入或卖出信号 — 请结合多种视角综合判断。 了解如何解读这些评分 →
📚 了解更多
在文本中查找 STIM in your text
粘贴任何文章、记录或帖子 — 工具将提取 STIM 以及每一个其他隐藏的股票代码。
免责声明：本数据仅供教育和娱乐用途，不构成金融建议。市场数据可能存在延迟。在做出投资决策之前，请始终进行自己的研究。
数据最后更新： 2026-07-16.